HC Wainwright & Co. Initiates Coverage On Biohaven with Buy Rating, Announces Price Target of $50
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao has initiated coverage on Biohaven (NYSE:BHVN) with a Buy rating and set a price target of $50.
December 22, 2023 | 11:12 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biohaven has been given a Buy rating and a price target of $50 by HC Wainwright & Co. analyst Douglas Tsao.
The initiation of coverage by an analyst with a Buy rating typically suggests a positive outlook on the stock's future performance. The price target of $50 indicates a potential upside from the current trading price, which may attract investor interest and drive short-term price movement upwards.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100